Your session is about to expire
← Back to Search
Behavioural Intervention
"Up To Me" Program for Mental Illness on College Campuses
N/A
Waitlist Available
Led By Kristin Kosyluk
Research Sponsored by University of South Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to week 3, week 7, week 15 and 27 for all participants
Awards & highlights
No Placebo-Only Group
Summary
This trial will evaluate a program to help college students with mental illness improve their living and participation in their community. Outcomes expected: better integration, self-esteem & self-determination, disclosure of illness for support & better achievement.
Who is the study for?
This trial is for college students over 18 at USF who have psychiatric disabilities and may feel shame or secrecy about their mental illness. It's not for those with only substance abuse issues or graduating within 6 months of starting the intervention.
What is being tested?
The 'Up To Me' program, which includes three lessons to reduce stigma around mental illness on campus, is being tested. Students are randomly assigned to receive the program with or without an additional booster session.
What are the potential side effects?
Since this is a psychoeducational intervention rather than a medication, traditional physical side effects are not expected. However, discussing mental health openly could potentially cause emotional discomfort.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline to week 3, week 7, week 15 and 27 for all participants
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to week 3, week 7, week 15 and 27 for all participants
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Self-Determination Scale
Self-Stigma of Mental Illness Scale-Short Form
Stigma Stress Scale
+2 moreSecondary study objectives
Academic Persistence
Academic and Intellectual Development Scale
Actual Help Seeking Questionnaire
+15 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Intervention + No BoosterExperimental Treatment1 Intervention
This arm will have n=67 participants. The Up To Me behavioral intervention will be administered via 2-hour sessions over three consecutive weeks. During these sessions, participants will complete worksheets from the Up To Me workbook.
Group II: Intervention + BoosterExperimental Treatment1 Intervention
This arm will have n=67 participants. The Up To Me behavioral intervention will be administered via 2-hour sessions over three consecutive weeks. During these sessions, participants will complete worksheets from the Up To Me workbook. Additionally, participants randomized to this arm will complete an additional session 4 weeks after the third session of the intervention.
Group III: Waitlist ControlActive Control1 Intervention
This arm will have n=67 participants. Those randomized to this arm will be engaged in "treatment as usual", participating in the same services and activities that they were engaged with prior to recruitment into the study.
Find a Location
Who is running the clinical trial?
University of South FloridaLead Sponsor
425 Previous Clinical Trials
190,274 Total Patients Enrolled
National Institute on Disability, Independent Living, and Rehabilitation ResearchFED
79 Previous Clinical Trials
9,646 Total Patients Enrolled
Temple UniversityOTHER
315 Previous Clinical Trials
88,752 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am over 18 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention + Booster
- Group 2: Waitlist Control
- Group 3: Intervention + No Booster
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger